Sign In
Get Clay Free →

Suggestions

    Matthew Lumley

    Venture Partner and CEO

    Dr. Matthew Lumley is a highly accomplished professional with a strong educational background and extensive experience in the pharmaceutical and healthcare industries.

    He holds a Doctor of Philosophy (PhD) in Cardiovascular Physiology and Clinical Research from King's College London, showcasing his dedication to academic excellence.

    Dr. Lumley also pursued a Diploma in Pharmaceutical Medicine from The Faculty of Pharmaceutical Medicine, along with a Bachelor of Medicine, Bachelor of Surgery (MBBS) and a Bachelor of Science (BSc) in Human Physiology and Imaging, both from Imperial College London. Additionally, he obtained a Certificate in Medical Education from UCL, further highlighting his commitment to continuous learning and development.

    Throughout his career, Dr. Lumley has held key positions in prestigious organizations, demonstrating his expertise and leadership capabilities. He has served as a Venture Partner at Medicxi, Chief Executive Officer at Myosana Therapeutics, Inc, and as a Board Member for the same organization.

    His professional journey includes roles such as Senior Director - Rare Disease Clinical Development at Moderna, Medical Director - Rare Diseases at Pfizer, and Health and Value Team Leader at Pfizer.

    Dr. Lumley has also contributed significantly to Pfizer as a Global Innovative Pharma Medical Affairs Manager with a focus on Cardiovascular issues.

    Prior to these roles, he served as a British Heart Foundation Clinical Research Training Fellow at King's College London and a Biomedical Research Centre Clinical Research Fellow at Guy's and St Thomas' NHS Foundation Trust, highlighting his diverse experience in both academic and clinical settings.

    Matthew Lumley
    Add to my network

    Location

    United Kingdom